Synairgen announces global strategic partnership with Ashfield Engage
Southampton, UK: Synairgen plc (LSE: SNG), the respiratory company developing SNG001 (inhaled interferon-beta or IFN-beta) for the treatment of COVID-19
B-cell lymphoma clinical trials now open on the TrialWire Platform
ADELAIDE, AUS – TrialWire(TM) is pleased to announce new B-cell lymphoma clinical studies are now available on the TrialWire Platform.
CPhI Predictions for 2022
CPhI Predictions for 2022: high manufacturing demand to constrain global ingredients, partnering options and available CDMO capacity. Continued stellar growth
5 HIPAA Compliance Tips For Healthcare Professionals
Healthcare professionals who comply with the Health Insurance Portability and Accountability Act (HIPAA) will benefit by removing the risk of
What Changes To Your Lifestyle Need To Be Done After Bariatric Surgery
Getting bariatric surgery is a lifesaver for many people. It can dramatically improve the quality of life of those that
Prescription Drugs and Their Role in D.U.I. Incidents
Impaired driving due to prescription medication is often given less attention than driving under the influence of illegal drugs. Yet,